PMID: 6978717Apr 1, 1982Paper

Histone antibodies in systemic lupus erythematosus. A possible diagnostic tool

Arthritis and Rheumatism
M GioudJ C Monier

Abstract

Antibodies to total histones and histone fractions H1, H2a-H4, H2b, and H3 were measured in serum samples from 61 patients with systemic lupus erythematosus (SLE), 33 with rheumatoid arthritis, 17 with systemic sclerosis, and 20 with various other diseases by use of a sensitive immunoenzymatic assay. Histone antibodies were present in 52.4% of the SLE samples whereas only 1 of the samples from other diseases was positive (systemic sclerosis). The presence of these antibodies in SLE patients was not associated with any specific clinical manifestations, but was correlated with activity of the disease: 87% (20 of 23) of patients with active SLE, in particular 9 of 9 not yet treated, showed histone antibody whereas only 18% (4 of 22) of samples from patients with inactive SLE were positive. We believe that the measurement of histone antibodies would be a useful addition to the present laboratory parameters (antinuclear and double-stranded DNA antibodies and circulating immune complexes) for the diagnosis and progression of systemic lupus erythematosus, particularly since they seem to appear during or just before the onset of an active phase and tend to be absent during remission.

References

Apr 22, 1975·Biochemistry·D Goldblatt, M Bustin
Jan 1, 1976·Scandinavian Journal of Immunology·E M TanP Robitaille
Dec 1, 1979·Clinical and Experimental Dermatology·A L ClaudyA Alario
Jul 1, 1977·Arthritis and Rheumatism·S J RiveroD Alarcón-Segovia
Sep 1, 1978·The Journal of Clinical Investigation·M J Fritzler, E M Tan

❮ Previous
Next ❯

Citations

Aug 15, 1998·Arthritis and Rheumatism·G SchettJ S Smolen
Jan 1, 1996·Molecular Biology Reports·M J Fritzler
Oct 17, 1998·Clinical Reviews in Allergy & Immunology·G Q ShenJ B Peter
Sep 27, 1986·Journal of Immunological Methods·M Gripenberg, P Kurki
Oct 1, 1984·Veterinary Immunology and Immunopathology·O CostaM Fontaine
Oct 16, 2002·Biochemical and Biophysical Research Communications·E Helen KempPhilip P Watson
Apr 25, 2007·Transplantation·Toshiaki NakanoChao-Long Chen
Jun 26, 1998·Journal of Gastroenterology and Hepatology·E Jaeckel, M P Manns
Jun 26, 1998·Journal of Gastroenterology and Hepatology·M ChenM Nishioka
Nov 15, 2000·Lancet·S R KnowlesN H Shear
Nov 21, 2012·Actas dermo-sifiliográficas·M PretelA España
Dec 25, 2009·Journal of Autoimmunity·Markus H HoffmannGünter Steiner
Oct 1, 1994·Journal of the American Academy of Dermatology·S SatoK Takehara
Aug 16, 2008·Journal of Autoimmunity·Lefkothea PichaPanayiotis G Vlachoyiannopoulos
May 28, 2008·Transplant Immunology·Toshiaki NakanoChao-Long Chen
Jul 18, 2008·Journal of Clinical Laboratory Analysis·Xiao-Yun SunZhan-Guo Li
Jan 1, 1997·Research in Veterinary Science·S C BellS D Carter
Oct 1, 1985·Medical Hypotheses·K M Fischer
Jul 1, 1985·Clinics in Dermatology·K B Kulick, M Reichlin
Jul 1, 1991·Clinical Immunology and Immunopathology·A CaturlaE G de la Concha
Aug 1, 1989·Clinical Immunology and Immunopathology·H WakuiA B Miura
Jan 1, 1985·Scandinavian Journal of Rheumatology. Supplement·R SmeenkT Swaak
Jul 1, 1985·Clinical Immunology and Immunopathology·R L RubinE M Tan
May 1, 1984·Clinical and Experimental Dermatology·N R Rowell
Jul 6, 2005·Nihon Rinshō Men'eki Gakkai kaishi = Japanese journal of clinical immunology·Akira Suwa
Dec 24, 2005·Autoimmunity·Piercarlo Sarzi-PuttiniAndrea Doria
Mar 1, 1994·Arthritis and Rheumatism·S SatoK Takehara
Dec 22, 2017·Rheumatology·Stefan VordenbäumenMatthias Schneider

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.